E
Mural Oncology plc MURA
$2.09 -$0.01-0.24% NASDAQ
Recommendation
Prev Close
$2.09
Volume
131,347
Avg Vol (90D)
231,633
Market Cap
$36.21M
Dividend & Yield
--
52-Week Range
$0.95 - $4.74
P/E (TTM)
--
EPS (TTM)
-$8.58
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Implied VHT Analyst Target Price: $313
11/4/2025 - ETF Channel
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp. ...
10/24/2025 - GuruFocus
Mural Oncology Approves Acquisition by XRA 5 Corp.
10/24/2025 - TipRanks Financial Blog
Mural Oncology (MURA) Shareholders Approve Acquisition by XRA 5 Corp.
10/24/2025 - GuruFocus
Mural Oncology shareholders approve acquisition by XRA 5 Corp.
10/24/2025 - The Fly
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
10/24/2025 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders
9/29/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Reminds Shareholders of Upcoming Merger Deadlines AMWD, PHLT, ARIS, and MURA
9/28/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - AMWD, PHLT, ARIS, and MURA
9/27/2025 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders
9/27/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger AMWD, PHLT, ARIS, and MURA
9/26/2025 - Globe Newswire
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of ...
9/24/2025 - GuruFocus
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of ...
9/24/2025 - GuruFocus
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
9/23/2025 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARIS, MTSR, GTLS, MURA on Behalf of Shareholders
9/23/2025 - Globe Newswire
Mural Oncology Plc Announces Acquisition by XOMA Royalty Corporation
9/23/2025 - TipRanks Financial Blog
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger GTLS, PHLT, ARIS, and MURA
9/23/2025 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBAN, HBI, NWE, MURA on Behalf of Shareholders
9/23/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate Merger - GTLS, PHLT, ARIS, and MURA
9/22/2025 - PR Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, GES, MURA, TZUP on Behalf of Shareholders
9/11/2025 - Globe Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger NWE, GES, MURA, and TZUP
9/11/2025 - Globe Newswire
Trium Capital LLP Acquires Significant Stake in Mural Oncology PLC
9/5/2025 - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NWE, BKH, MURA, SCPH on Behalf of Shareholders
8/28/2025 - PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology ...
8/27/2025 - GuruFocus
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Mural Oncology plc (NASDAQ: MURA)
8/27/2025 - PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$131.93M
EBIT (TTM)
-$135.69M
Net Income (TTM)
-$147.15M
Balance Sheet
Total Assets (Q)
$87.56M
Total Debt (Q)
$5.17M
Total Liabilities (Q)
$28.77M
Book Value Per Share (Q)
$3.40
Cash Flow
Cash from Operations (TTM)
-$130.01M
Cash from Investing (TTM)
$85.29M
Cash from Financing (TTM)
$224.00K
Net Change in Cash (TTM)
-$44.49M
Filings
Filing Date
Monday, August 4, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-0.24%
30-Day Total Return
0.72%
60-Day Total Return
31.13%
90-Day Total Return
-15.93%
Year to Date Total Return
-34.84%
1-Year Total Return
-39.74%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $0.95
52-week High
Feb 07, 2025 - $4.74
Valuation
Market Cap
$36.21M - Nano Cap
Enterprise Value
-$35.71M
Price/Sales (TTM)
--
Price/Book (Q)
0.61
Dividends and Shares
Shares Outstanding
17.27
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.muraloncology.com
Phone Number
353 1 905 8020
Address
10 Earlsfort Terrace
Dublin, D02 T380
Country
Ireland
Year Founded
2017
Business Description
Sector
--
Industry
--
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company’s lead product... more
NASDAQ 11/04/2025 12:37PM Eastern Quotes delayed